Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Extreme Risk Protection Order Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
HOUSE - H.R. 1236 the Extreme Risk Protection Order Act Contacted by Representative Carbajal to sign on in support of their introduction of H.R. 1236 the Extreme Risk Protection Order Act.
Investing for the People Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2019 · third_quarter · Q3
HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER Signed onto letter led by friends of AHRQ as House and Senate begin Fiscal 2020 conference negotiations amongst appropriators urging them to support a final funding level equal to, or above the House-passed level of $358.2 million for AHRQ. HOUSE/SENATE - H.R. 2328 Reauthorizing and Extending Americas Community Health Act Signed coalition letter led by NIDDK to House and Senate leaders (Reps. Nancy Pelosi and Kevin McCarthy and Sens. Mitch McConnell and Charles Schumer) urging reauthorization of the Special Diabetes Program through H.R. 2328 Reauthorizing and Extending America's Community Health Act or the "REACH Act." HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER Signed onto letter led by the Ad Hoc Group Steering Committee for Medical Research urging House and Senate appropriators to ensure quick enactment of Labor-HHS-Education appropriations bill that provides robust, sustained funding for medical research. This letter has an emphasis on NIH funding. SENATE - Funding Bill FY20 Signed onto Giffords Coalition letter urging Senate leadership to include the House passed Fiscal Year 2020 Labor, Health and Human Services, Education, and Related Agencies funding bill, which includes $50 million for the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to conduct research into gun violence.
Source: Senate LDA
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. BUD - HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
Investing for the People Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
REACH Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER Signed onto letter led by friends of AHRQ as House and Senate begin Fiscal 2020 conference negotiations amongst appropriators urging them to support a final funding level equal to, or above the House-passed level of $358.2 million for AHRQ. HOUSE/SENATE - H.R. 2328 Reauthorizing and Extending Americas Community Health Act Signed coalition letter led by NIDDK to House and Senate leaders (Reps. Nancy Pelosi and Kevin McCarthy and Sens. Mitch McConnell and Charles Schumer) urging reauthorization of the Special Diabetes Program through H.R. 2328 Reauthorizing and Extending America's Community Health Act or the "REACH Act." HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER Signed onto letter led by the Ad Hoc Group Steering Committee for Medical Research urging House and Senate appropriators to ensure quick enactment of Labor-HHS-Education appropriations bill that provides robust, sustained funding for medical research. This letter has an emphasis on NIH funding. SENATE - Funding Bill FY20 Signed onto Giffords Coalition letter urging Senate leadership to include the House passed Fiscal Year 2020 Labor, Health and Human Services, Education, and Related Agencies funding bill, which includes $50 million for the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to conduct research into gun violence.
Leading Infrastructure for Tomorrow’s America Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. BUD - HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
Leading Infrastructure for Tomorrow’s America Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
Malala Yousafzai Scholarship Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
Reauthorization of the Higher Education Act; H.R. 4508 - Promoting Real Opportunity, Success and Prosperity through Education Reform Act; H. R. 6543 - The Aim Higher Act; Graduate and professional education; GRAD Plus; Public Service Loan Forgiveness; Student loan issues affecting pharmacy education; Interprofessional education issues; Title IX reform
American Dream and Promise Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
American Dream and Promise Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM ACT (S. 874/H.R. 6) Signed onto Health Professionals Coalition letter in support of the DREAM Act (S. 874/H.R. 6). This letter urges the Senate to adopt H.R. 6 the Dream and Promise Act recently passed by the House or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin. SENATE - Letter to Secretary Azar of Department of HHS Singed onto letter led by the Coalition on Fetal Tissue Research expressing concerns regarding two NIH guide notices Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research and Clarifying Competing Application Instructions and Notice of Publication of Frequently Asked Questions (FAQs) Regarding Proposed Human Fetal Tissue Research. The letter sent to Secretary Azar expresses concerns that both the policy underlying these notices (i.e., the requirement that human fetal tissue research proposals be subject to an additional layer of review) and the specific requirements of these notices will create substantial barriers to important biomedical research, jeopardize the integrity of the peer-review process, and create an unnecessarily cumbersome and bureaucratic process for reviewing crucial research.
American Dream and Promise Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
Strengthening Health Care and Lowering Prescription Drug Costs Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - Public Health Funding Restoration Act Worked with Senator Richard Blumenthal (D-CT) on supporting the introduction of the Public Health Restoration Act and signed on as a supporting organization. ADMINISTRATION - Letter to White House, OMB, POTUS and HHS Opposing FDA Guidance Signed onto letter led by Friends of Cancer research to the Administration, Mick Mulvaney, Russel Vought, Trump and Alexander Azar voicing opposition to FDA guidance documents. SENATE - Cannabidiol and Marijuana Research Expansion Act Signed letter led by American Psychological Association addressed to Senate leaders asking for the reintroduction of the Cannabidiol and Marijuana Research Expansion Act. HOUSE - Rep. Buddy Carter Amendment Rec. to H.R. 987 Strengthening Healthcare and Lowering Prescription Drug Cost Act Contacted by Rep. Buddy Carters office regarding amendment to H.R. 987 Strengthening Healthcare and Lower Prescription Drug Cost Act which included provision regarding outreach to colleges of pharmacy by the Secretary of HHS and Education with respect to materials related to generic drugs and biosimilar.
Strengthening Health Care and Lowering Prescription Drug Costs Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - Public Health Funding Restoration Act Worked with Senator Richard Blumenthal (D-CT) on supporting the introduction of the Public Health Restoration Act and signed on as a supporting organization. ADMINISTRATION - Letter to White House, OMB, POTUS and HHS Opposing FDA Guidance Signed onto letter led by Friends of Cancer research to the Administration, Mick Mulvaney, Russel Vought, Trump and Alexander Azar voicing opposition to FDA guidance documents. SENATE - Cannabidiol and Marijuana Research Expansion Act Signed letter led by American Psychological Association addressed to Senate leaders asking for the reintroduction of the Cannabidiol and Marijuana Research Expansion Act. HOUSE - Rep. Buddy Carter Amendment Rec. to H.R. 987 Strengthening Healthcare and Lowering Prescription Drug Cost Act Contacted by Rep. Buddy Carters office regarding amendment to H.R. 987 Strengthening Healthcare and Lower Prescription Drug Cost Act which included provision regarding outreach to colleges of pharmacy by the Secretary of HHS and Education with respect to materials related to generic drugs and biosimilar.
Strengthening Health Care and Lowering Prescription Drug Costs Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
HOUSE - H.R. 987/Discussion of Pharmacy Education Visiting Office of office Rep. Lucy McBath in response to an amendment offered by the representative to H.R. 987. The amendment calls for DHHS and DoEd to do all needed outreach to make sure faculty and students at colleges of pharmacy have all necessary materials about generic drugs and biosimilar biological products. AACP welcomes the representatives support for pharmacists and pharmacy students.
Dream Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
Dream Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM ACT (S. 874/H.R. 6) Signed onto Health Professionals Coalition letter in support of the DREAM Act (S. 874/H.R. 6). This letter urges the Senate to adopt H.R. 6 the Dream and Promise Act recently passed by the House or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin. SENATE - Letter to Secretary Azar of Department of HHS Singed onto letter led by the Coalition on Fetal Tissue Research expressing concerns regarding two NIH guide notices Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research and Clarifying Competing Application Instructions and Notice of Publication of Frequently Asked Questions (FAQs) Regarding Proposed Human Fetal Tissue Research. The letter sent to Secretary Azar expresses concerns that both the policy underlying these notices (i.e., the requirement that human fetal tissue research proposals be subject to an additional layer of review) and the specific requirements of these notices will create substantial barriers to important biomedical research, jeopardize the integrity of the peer-review process, and create an unnecessarily cumbersome and bureaucratic process for reviewing crucial research.
Dream Act of 2019
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
Aim Higher Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
Reauthorization of the Higher Education Act; H.R. 4508 - Promoting Real Opportunity, Success and Prosperity through Education Reform Act; H. R. 6543 - The Aim Higher Act; Graduate and professional education; GRAD Plus; Public Service Loan Forgiveness; Student loan issues affecting pharmacy education; Interprofessional education issues; Title IX reform
Pharmacy and Medically Underserved Areas Enhancement Act
Client: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
S. 109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Status of pharmacists as health care providers for Medicare/Medicaid services
HOUSE - H.R. 1236 the Extreme Risk Protection Order Act Contacted by Representative Carbajal to sign on in support of their introduction of H.R. 1236 the Extreme Risk Protection Order Act.
SENATE - DREAM ACT (S. 874/H.R. 6) Signed onto Health Professionals Coalition letter in support of the DREAM Act (S. 874/H.R. 6). This letter urges the Senate to adopt H.R. 6 the Dream and Promise Act recently passed by the House or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin. SENATE - Letter to Secretary Azar of Department of HHS Singed onto letter led by the Coalition on Fetal Tissue Research expressing concerns regarding two NIH guide notices Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research and Clarifying Competing Application Instructions and Notice of Publication of Frequently Asked Questions (FAQs) Regarding Proposed Human Fetal Tissue Research. The letter sent to Secretary Azar expresses concerns that both the policy underlying these notices (i.e., the requirement that human fetal tissue research proposals be subject to an additional layer of review) and the specific requirements of these notices will create substantial barriers to important biomedical research, jeopardize the integrity of the peer-review process, and create an unnecessarily cumbersome and bureaucratic process for reviewing crucial research.
HOUSE - H.R. 987/Discussion of Pharmacy Education Visiting Office of office Rep. Lucy McBath in response to an amendment offered by the representative to H.R. 987. The amendment calls for DHHS and DoEd to do all needed outreach to make sure faculty and students at colleges of pharmacy have all necessary materials about generic drugs and biosimilar biological products. AACP welcomes the representatives support for pharmacists and pharmacy students.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2019 · second_quarter · 2A
Status of pharmacists as health care providers for Medicare/Medicaid services
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. BUD - HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
SENATE - Public Health Funding Restoration Act Worked with Senator Richard Blumenthal (D-CT) on supporting the introduction of the Public Health Restoration Act and signed on as a supporting organization. ADMINISTRATION - Letter to White House, OMB, POTUS and HHS Opposing FDA Guidance Signed onto letter led by Friends of Cancer research to the Administration, Mick Mulvaney, Russel Vought, Trump and Alexander Azar voicing opposition to FDA guidance documents. SENATE - Cannabidiol and Marijuana Research Expansion Act Signed letter led by American Psychological Association addressed to Senate leaders asking for the reintroduction of the Cannabidiol and Marijuana Research Expansion Act. HOUSE - Rep. Buddy Carter Amendment Rec. to H.R. 987 Strengthening Healthcare and Lowering Prescription Drug Cost Act Contacted by Rep. Buddy Carters office regarding amendment to H.R. 987 Strengthening Healthcare and Lower Prescription Drug Cost Act which included provision regarding outreach to colleges of pharmacy by the Secretary of HHS and Education with respect to materials related to generic drugs and biosimilar.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2019 · second_quarter · Q2
Provider status for pharmacists in Medicare/Medicaid
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
SENATE - Public Health Funding Restoration Act Worked with Senator Richard Blumenthal (D-CT) on supporting the introduction of the Public Health Restoration Act and signed on as a supporting organization. ADMINISTRATION - Letter to White House, OMB, POTUS and HHS Opposing FDA Guidance Signed onto letter led by Friends of Cancer research to the Administration, Mick Mulvaney, Russel Vought, Trump and Alexander Azar voicing opposition to FDA guidance documents. SENATE - Cannabidiol and Marijuana Research Expansion Act Signed letter led by American Psychological Association addressed to Senate leaders asking for the reintroduction of the Cannabidiol and Marijuana Research Expansion Act. HOUSE - Rep. Buddy Carter Amendment Rec. to H.R. 987 Strengthening Healthcare and Lowering Prescription Drug Cost Act Contacted by Rep. Buddy Carters office regarding amendment to H.R. 987 Strengthening Healthcare and Lower Prescription Drug Cost Act which included provision regarding outreach to colleges of pharmacy by the Secretary of HHS and Education with respect to materials related to generic drugs and biosimilar.
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY via AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
2019 · first_quarter · Q1
Appropriations and budget for Departments of Labor, Health and Human Services, Education and related agencies. Federal funding for research, particularly health/health services and biomedical research Title VII programs
S. 109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Reauthorization of the Higher Education Act; H.R. 4508 - Promoting Real Opportunity, Success and Prosperity through Education Reform Act; H. R. 6543 - The Aim Higher Act; Graduate and professional education; GRAD Plus; Public Service Loan Forgiveness; Student loan issues affecting pharmacy education; Interprofessional education issues; Title IX reform
Educate congressional staff on mission and value of academic pharmacy; Opioid crisis;
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE